Same price level when APX announced Figure 8 acquisition to make it a leader in this niche market. APX had a crappy year by its own standards a crappy 25% revenue growth but needs more as margins are not top tier so needs more revenue. Having said that NPAT and EPS will spike as FY 2019 was all about integrating Figure 8 and China expansion and that level of capex won't be on FY 20 results. I will be surprised if Capex is greater than $3M as opposed to $15M FY19 that's where NPAT will get a spike. APX will eventually be a human to technology company and has the balance sheet to make another Figure 8 type acquisition. FCF is growing 50% y-o-y. Might take another 2-3 years but a major acquisition id in the offing won' t have to wait too much longer.
- Forums
- ASX - By Stock
- APX
- Ann: Trading Update
Ann: Trading Update, page-124
Featured News
Add APX (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.75 |
Change
0.060(2.23%) |
Mkt cap ! $717.0M |
Open | High | Low | Value | Volume |
$2.75 | $2.84 | $2.69 | $25.98M | 9.385M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 33184 | $2.75 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.76 | 3556 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 33184 | 2.750 |
1 | 364 | 2.740 |
2 | 39526 | 2.730 |
2 | 3550 | 2.720 |
2 | 8000 | 2.710 |
Price($) | Vol. | No. |
---|---|---|
2.760 | 3556 | 1 |
2.770 | 2834 | 1 |
2.780 | 7220 | 1 |
2.790 | 8007 | 2 |
2.800 | 22676 | 5 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
APX (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online